Global Plasma Fractionation Market 2022-2028
Plasma fractionation is the downstream processing of plasma that has been harvested by donors. It breaks plasma into individual proteins, or plasma fractions. The global plasma fractionation market is likely to register a CAGR of over 6.4% with an incremental growth of USD 14 billion during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global plasma fractionation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the plasma fractionation industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for plasma fractionation can be segmented by product: immunoglobulins, albumins, coagulation factor concentrates, others. The immunoglobulins segment held the largest revenue share in 2021. Plasma fractionation market is further segmented by application: neurology, immunology, hematology, others. Among these, the neurology segment was accounted for the highest revenue generator in 2021. Based on end user, the plasma fractionation market is segmented into: hospitals and clinics, research laboratories, others. The hospitals and clinics segment captured the largest share of the market in 2021. On the basis of region, the plasma fractionation market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, North America had the largest share in the global plasma fractionation market.
By product:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook